Saturday, August 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Oracle Shares Plunge as Investor Confidence Evaporates

Felix Baarz by Felix Baarz
November 20, 2025
in AI & Quantum Computing, Analysis, Nasdaq, Tech & Software
0
Oracle Stock
0
SHARES
139
VIEWS
Share on FacebookShare on Twitter

A staggering $300 billion in market capitalization has vanished from Oracle in just two months. This dramatic decline represents more than a typical market correction; it signals a rapid withdrawal of investor confidence. Since the technology giant announced a multi-billion dollar partnership with OpenAI in September, its stock has been in a sustained downward spiral. Market participants are expressing profound skepticism about whether Oracle’s aggressive, debt-fueled artificial intelligence expansion will yield returns or potentially jeopardize the company’s financial stability.

Mounting Debt for AI Ambitions Sparks Concern

The core issue unsettling markets is not Oracle’s AI strategy itself, but its chosen method of financing. The company intends to take on billions in additional debt to scale its artificial intelligence infrastructure. Wall Street is openly questioning if these massive capital expenditures will ever generate the promised returns, or if Oracle is instead assuming an unsustainable level of risk. This growing debt burden is already making an impact: not only has the stock suffered, but Oracle’s corporate bonds have also faced selling pressure.

Compounding these worries are concerns about shrinking profit margins. The operational costs for running their expansive infrastructure are rising rapidly, while it remains uncertain whether future revenue can keep pace. Even positive developments—such as the recent recognition of Oracle Financial Services for its application of AI in risk technology—have failed to stem the negative sentiment. Investor trust has been fundamentally shaken, establishing a clearly negative trend.

Should investors sell immediately? Or is it worth buying Oracle?

Bear Market Territory Confirmed with 33% Decline

The technical picture confirms the bleak outlook. Oracle has officially entered bear market territory, with its shares now trading more than 30% below their recent peaks. By the end of October, the stock had fallen into this feared zone, erasing all gains achieved following its last major quarterly report. The share price has broken through key moving averages that provided reliable support for most of the year. Technical analysts are now warning that the next significant support level may not appear until the $200 mark—the level from which its last major upward movement originated.

The critical question facing investors is whether this represents an exaggerated panic reaction or the beginning of a more prolonged decline.

Ad

Oracle Stock: Buy or Sell?! New Oracle Analysis from August 8 delivers the answer:

The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 8.

Oracle: Buy or sell? Read more here...

Tags: Oracle
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Nvidia Stock
AI & Quantum Computing

Nvidia’s Latest Surge Is About More Than a Single Order

August 8, 2026
Applovin Stock
Analysis

AppLovin’s $40 Billion Wake-Up Call: When a 53% Growth Rate Isn’t Enough

August 8, 2026
Atlassian Stock
Earnings

Atlassian’s €128.80 Spike: A Profitability Inflection Point Arrives Just as Growth Slows

August 8, 2026
Next Post
Unitedhealth Stock

Can a Former FDA Chief Revive UnitedHealth's Prospects?

Eli Lilly Stock

Eli Lilly Expands Innovation Network with Strategic Philadelphia Hub

Pepsi Stock

PepsiCo's Dividend Surprise Amid Major Restructuring

Recommended

Biotechnology Stock Bull Market

Analyst Reiterates Buy Rating and 12 Price Target for Shattuck Labs Citing Promising Potential in Biotech Sector

2 years ago
Sangamo Therapeutics Stock

A Regulatory Milestone Sparks Renewed Interest in Sangamo Therapeutics

7 months ago
Diginex Stock

Leadership Shift at Diginex as ESG Software Founder Takes Helm

6 months ago
Novo Nordisk Stock

Novo Nordisk’s Bold Gambit: Price Cuts and Restructuring Amid Market Pressure

9 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Petrobras Delivers Record-Breaking Quarter, But Investors Keep Their Distance

Milan Fertility Clinic Suspended After Embryo Mix-Up Sparks Safety Reforms Across Europe

AppLovin’s $40 Billion Wake-Up Call: When a 53% Growth Rate Isn’t Enough

Atlassian’s €128.80 Spike: A Profitability Inflection Point Arrives Just as Growth Slows

Amazon’s Three-Trillion-Dollar Moment: A Founder’s Exit, a $220 Billion Wager, and the Fine Print Behind the Record Numbers

The AI Payoff Shifts: Airbnb, SpaceX, and Crypto Show Their Hand

Trending

Novo Nordisk Stock
European Markets

Novo Nordisk’s Oral Push Marks a Sales Milestone as Trial Setbacks and Rival Pressure Keep the Spotlight on the Pipeline

by SiterGedge
August 8, 2026
0

Novo Nordisk is getting one piece of good news that is easy to count: Wegovy has now...

Nvidia Stock

Nvidia’s Latest Surge Is About More Than a Single Order

August 8, 2026
Plug Power Stock

Plug Power’s Balancing Act: Property Sales Fund the Present While Australia’s Hydrogen Hub Points to the Future

August 8, 2026
Petrobras Stock

Petrobras Delivers Record-Breaking Quarter, But Investors Keep Their Distance

August 8, 2026
FALLBACK Stock

Milan Fertility Clinic Suspended After Embryo Mix-Up Sparks Safety Reforms Across Europe

August 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Novo Nordisk’s Oral Push Marks a Sales Milestone as Trial Setbacks and Rival Pressure Keep the Spotlight on the Pipeline
  • Nvidia’s Latest Surge Is About More Than a Single Order
  • Plug Power’s Balancing Act: Property Sales Fund the Present While Australia’s Hydrogen Hub Points to the Future

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com